- Home
- PYPD vs FEMY Comparison
PYPD vs FEMY Comparison
Compare PYPD & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- FEMY
- Stock Information
- Founded
- PYPD 2008
- FEMY 2004
- Country
- PYPD Israel
- FEMY United States
- Employees
- PYPD N/A
- FEMY N/A
- Industry
- PYPD Medical/Dental Instruments
- FEMY Medical/Dental Instruments
- Sector
- PYPD Health Care
- FEMY Health Care
- Exchange
- PYPD Nasdaq
- FEMY Nasdaq
- Market Cap
- PYPD 24.2M
- FEMY 24.9M
- IPO Year
- PYPD 2020
- FEMY 2021
- Fundamental
- Price
- PYPD $3.56
- FEMY $0.95
- Analyst Decision
- PYPD Strong Buy
- FEMY Strong Buy
- Analyst Count
- PYPD 2
- FEMY 3
- Target Price
- PYPD $12.00
- FEMY $10.00
- AVG Volume (30 Days)
- PYPD 8.1K
- FEMY 245.5K
- Earning Date
- PYPD 11-13-2024
- FEMY 11-12-2024
- Dividend Yield
- PYPD N/A
- FEMY N/A
- EPS Growth
- PYPD N/A
- FEMY N/A
- EPS
- PYPD N/A
- FEMY N/A
- Revenue
- PYPD N/A
- FEMY $1,260,643.00
- Revenue This Year
- PYPD N/A
- FEMY $135.27
- Revenue Next Year
- PYPD N/A
- FEMY $310.75
- P/E Ratio
- PYPD N/A
- FEMY N/A
- Revenue Growth
- PYPD N/A
- FEMY 15.33
- 52 Week Low
- PYPD $2.95
- FEMY $0.73
- 52 Week High
- PYPD $9.20
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- PYPD 54.93
- FEMY 31.56
- Support Level
- PYPD $3.30
- FEMY $1.10
- Resistance Level
- PYPD $3.59
- FEMY $1.18
- Average True Range (ATR)
- PYPD 0.21
- FEMY 0.09
- MACD
- PYPD 0.02
- FEMY -0.04
- Stochastic Oscillator
- PYPD 68.27
- FEMY 0.62
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.